Airat F. Khalirakhmanov

Airat F. Khalirakhmanov

Auto-generated profile, based on publicly available information

Airat F. Khalirakhmanov

Medical and Sanitary Unit, Kazan (Volga Region) Federal University; Kazan (Volga Region) Federal University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2021 in Acta Naturae
Verified
Journal Article
Open access
PDF file
AKAirat F. Khalirakhmanov
Airat F. Khalirakhmanov
KIKamilla Idrisova
Kamilla Idrisova
RGRaushaniya F. Gajfullina
Raushaniya F. Gajfullina
SZSergey V. Zinchenko
Sergey V. Zinchenko
RLRustem Litvinov
Rustem Litvinov
КПКиясов Андрей Павлович
Киясов Андрей Павлович
The novel coronavirus infection named COVID-19 was first detected in Wuhan, China, in December 2019, and it has been responsible for significant morbidity and mortality in scores of countries. At the time this article was being written, the number of infected and deceased patients continued to grow worldwide. Most patients with severe forms of the disease suffer from pneumonia and pulmonary insufficiency; in many cases, the disease is generalized and causes multiple organ failures and a dysfunction of physiological systems. One of the most serious and prognostically ominous complications from COVID-19 is coagulopathy, in particular, decompensated hypercoagulability with the risk of developing disseminated intravascular coagulation. In most cases, local and diffuse macro- and microthromboses are present, a condition which causes multiple-organ failure and thromboembolic complications. The causes and pathogenic mechanisms of coagulopathy in COVID-19 remain largely unclear, but they are associated with systemic inflammation, including the so-called cytokine storm. Despite the relatively short period of the ongoing pandemic, laboratory signs of serious hemostatic disorders have been identified and measures for specific prevention and correction of thrombosis have been developed. This review discusses the causes of COVID-19 coagulopathies and the associated complications, as well as possible approaches to their early diagnosis, prevention, and treatment.

23 July 2021 in Journal of radiology and nuclear medicine
Verified
Journal Article
Open access
PDF file
BSB. M. Sharafutdinov
B. M. Sharafutdinov
EAE. Yu. Antropova
E. Yu. Antropova
SRS. A. Ryzhkin
S. A. Ryzhkin
AKA. F. Khalirakhmanov
A. F. Khalirakhmanov
IKI. V. Klyucharov
I. V. Klyucharov
MMM. K. Mikhaylov
M. K. Mikhaylov
Choosing a treatment option for uterine fibroids is today one of the most relevant problems in gynecological practice. Thanks to the success of modern medicine and the increased level of the population’s culture, female patients seek medical help without waiting for the tumor to acquire significant sizes. However, in practice, there are cases when fibroids reach gigantic sizes. Hysterectomy is a traditional approach to treating uterine fibroids of these sizes according to the current clinical guidelines. The introduction of new high-tech treatments, such as uterine artery embolization, has led to a revision of radical surgery, by giving preference to alternative approaches especially in cases where the patient desires to preserve the reproductive organ. The paper describes a clinical case that confirms an individual approach to choosing a treatment option towards organ-sparing surgery for giant uterine fibroids. The use of endovascular embolization of the uterine arteries as a treatment for giant uterine fibroids is shown to be justified as an organ-sparing surgery if the patient desires to preserve reproductive function.